Search

everythinglearnresearchcommunity

for

Search:↓

USPlus®Derm may help hair growth and maintain stem cells in male pattern hair loss.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

L-borneol helps skin wound healing by promoting stem cell differentiation.

Polygoni Multiflori Radix may help reduce skin aging by lowering collagenase and elastase activity.

The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.

Compound 6 is a promising candidate for better wound healing.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

New treatments using stem cells and special materials show promise for severe eye surface disease.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

The cosmetic product improved melasma and skin quality without causing irritation.

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

Latanoprost and minoxidil effectively control hair loss and increase hair count.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

The new minoxidil gel reduces runoff and improves eyebrow hair growth.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Surgical debridement and targeted therapies can effectively heal chronic wounds in KID syndrome.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.

Intralesional steroid therapy is useful for treating various skin conditions.